Two teams investigated the base editing technique to convert the SMN2 gene into the SMN1 gene:
- in cell models of SMA, the exchange of the different base of exon 7 of the SMN2 gene was successful (with minimal “off-target”),
- In SMA mouse models, SMN protein production is increased and motor function is improved,
- the life span of the mice was extended.
This base-specific approach may allow modification of the SMN2 gene in all SMA patients, independent of the mutations that lead to loss of SMN1.